Free Trial

Sight Sciences (SGHT) Competitors

Sight Sciences logo
$4.06 +0.02 (+0.50%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$4.06 0.00 (0.00%)
As of 08/29/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SGHT vs. KMTS, EMBC, BBNX, TNDM, AXGN, SIBN, BVS, ZIMV, AVNS, and SMLR

Should you be buying Sight Sciences stock or one of its competitors? The main competitors of Sight Sciences include Kestra Medical Technologies (KMTS), Embecta (EMBC), Beta Bionics (BBNX), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Sight Sciences vs. Its Competitors

Sight Sciences (NASDAQ:SGHT) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

In the previous week, Kestra Medical Technologies had 4 more articles in the media than Sight Sciences. MarketBeat recorded 8 mentions for Kestra Medical Technologies and 4 mentions for Sight Sciences. Kestra Medical Technologies' average media sentiment score of 0.97 beat Sight Sciences' score of 0.52 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sight Sciences
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kestra Medical Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

55.5% of Sight Sciences shares are held by institutional investors. 30.9% of Sight Sciences shares are held by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Kestra Medical Technologies has a net margin of 0.00% compared to Sight Sciences' net margin of -64.23%. Kestra Medical Technologies' return on equity of 0.00% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-64.23% -59.38% -36.43%
Kestra Medical Technologies N/A N/A N/A

Sight Sciences presently has a consensus price target of $4.42, indicating a potential upside of 8.78%. Kestra Medical Technologies has a consensus price target of $27.33, indicating a potential upside of 69.35%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Kestra Medical Technologies is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Kestra Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Sight Sciences has higher revenue and earnings than Kestra Medical Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$76.30M2.79-$51.51M-$0.96-4.23
Kestra Medical Technologies$59.82M13.86-$113.81MN/AN/A

Summary

Kestra Medical Technologies beats Sight Sciences on 9 of the 13 factors compared between the two stocks.

Get Sight Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGHT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGHT vs. The Competition

MetricSight SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$211.56M$6.99B$5.66B$9.84B
Dividend YieldN/A1.20%3.93%4.04%
P/E Ratio-4.2326.1883.2726.61
Price / Sales2.7964.28451.26176.46
Price / CashN/A21.6837.7059.65
Price / Book3.037.0910.556.59
Net Income-$51.51M$176.42M$3.27B$266.12M
7 Day Performance-4.02%0.83%0.47%0.17%
1 Month Performance17.68%1.43%5.93%3.03%
1 Year Performance-40.03%6.64%48.79%19.98%

Sight Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGHT
Sight Sciences
2.0386 of 5 stars
$4.06
+0.5%
$4.42
+8.8%
-39.9%$211.56M$76.30M-4.23210Analyst Forecast
KMTS
Kestra Medical Technologies
1.2524 of 5 stars
$16.09
+0.2%
$27.33
+69.9%
N/A$824.15M$59.81M0.00300News Coverage
Positive News
Lockup Expiration
EMBC
Embecta
4.7184 of 5 stars
$13.48
-1.5%
$19.00
+40.9%
-11.8%$800.66M$1.12B9.432,100News Coverage
Positive News
Analyst Upgrade
BBNX
Beta Bionics
1.0146 of 5 stars
$17.26
+1.3%
$22.56
+30.7%
N/A$740.73M$65.12M0.00294
TNDM
Tandem Diabetes Care
4.5092 of 5 stars
$10.84
+0.2%
$22.67
+109.1%
-71.7%$731.10M$940.20M-3.512,650
AXGN
AxoGen
2.4488 of 5 stars
$15.49
+3.8%
$26.00
+67.9%
+24.2%$686.97M$203.27M-154.88450News Coverage
SIBN
SiBone
4.3515 of 5 stars
$15.54
+0.5%
$23.67
+52.3%
+2.2%$666.96M$167.18M-27.75350News Coverage
BVS
Bioventus
0.8708 of 5 stars
$7.18
-2.6%
N/AN/A$609.34M$573.28M14.741,200
ZIMV
ZimVie
0.629 of 5 stars
$18.95
+0.5%
$17.75
-6.3%
+9.8%$531.59M$449.75M-27.071,770News Coverage
AVNS
AVANOS MEDICAL
3.2915 of 5 stars
$11.24
+0.4%
N/A-50.6%$519.71M$687.80M-1.122,227News Coverage
Positive News
Analyst Revision
SMLR
Semler Scientific
3.2577 of 5 stars
$33.76
-0.2%
$81.75
+142.2%
+8.3%$500.99M$56.29M13.89120News Coverage

Related Companies and Tools


This page (NASDAQ:SGHT) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners